Waters Co. (NYSE:WAT) Holdings Raised by National Bank of Canada FI

National Bank of Canada FI boosted its position in Waters Co. (NYSE:WAT - Free Report) by 44.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,247 shares of the medical instruments supplier's stock after acquiring an additional 7,472 shares during the quarter. National Bank of Canada FI's holdings in Waters were worth $8,726,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Summit Trail Advisors LLC increased its holdings in Waters by 2.4% in the 3rd quarter. Summit Trail Advisors LLC now owns 1,198 shares of the medical instruments supplier's stock valued at $431,000 after purchasing an additional 28 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in shares of Waters by 3.8% in the third quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier's stock valued at $306,000 after purchasing an additional 31 shares during the period. Raymond James Trust N.A. grew its holdings in Waters by 2.4% during the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier's stock valued at $482,000 after purchasing an additional 32 shares in the last quarter. Linscomb Wealth Inc. increased its stake in Waters by 0.4% during the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier's stock worth $2,275,000 after buying an additional 34 shares during the period. Finally, Johnson Investment Counsel Inc. lifted its holdings in Waters by 3.2% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier's stock worth $314,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on WAT shares. Deutsche Bank Aktiengesellschaft lifted their target price on Waters from $310.00 to $325.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. Wells Fargo & Company upped their target price on Waters from $380.00 to $415.00 and gave the company an "overweight" rating in a research report on Monday, November 4th. Barclays raised their price target on shares of Waters from $330.00 to $360.00 and gave the stock an "underweight" rating in a research report on Monday, November 4th. Evercore ISI upped their price target on shares of Waters from $335.00 to $355.00 and gave the company an "in-line" rating in a report on Tuesday, October 1st. Finally, Stifel Nicolaus raised their price objective on shares of Waters from $332.00 to $360.00 and gave the stock a "hold" rating in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Waters has an average rating of "Hold" and an average target price of $371.33.

Waters Stock Performance

WAT traded down $2.24 on Thursday, hitting $383.03. 338,262 shares of the company's stock were exchanged, compared to its average volume of 440,501. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a fifty day moving average of $364.96 and a two-hundred day moving average of $335.46. Waters Co. has a twelve month low of $279.24 and a twelve month high of $397.02. The firm has a market cap of $22.74 billion, a PE ratio of 36.76, a P/E/G ratio of 7.14 and a beta of 1.01.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.68 by $0.25. The business had revenue of $740.30 million for the quarter, compared to the consensus estimate of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business's revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $2.84 EPS. On average, research analysts anticipate that Waters Co. will post 11.79 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.